Rabi Hanna: Gene Therapy Is Transforming Sickle Cell Disease
Rabi Hanna, Chairman, Department of Pediatric hematology-oncology and BMT at Cleveland Clinic Children’s at Cleveland Clinic, shared a post on LinkedIn:
“Today, on World Sickle Cell Day, I had the distinct honor of speaking at the Dutch Sickle Cell event in Amsterdam.
A special thank you to Erfan Nur for the invitation and the opportunity to join this critical conversation. It is a privilege to present an update on the rapidly evolving landscape of sickle cell gene therapy
While the scientific advancements we are seeing are groundbreaking, our work is far from finished.
The true measure of our success will be ensuring that these potentially curative treatments are accessible to everyone who needs them, regardless of geography or socioeconomic status.
Thank you to the Dutch SCD community for hosting such an inspiring event. Let’s continue pushing the boundaries of science while fighting for equitable care.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH
-
Sep 29, 2026, 11:32Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate
-
Sep 29, 2026, 10:54How Does Haemophilia Affect Motor Development in Infants? – EAHAD
-
Sep 29, 2026, 10:49Alison Davey: The Vital Role of Community Support in Bleeding Disorders